Article 2
Definitions For the purposes of this Regulation the following definitions shall apply: (a) "scheduled substance" means any substance listed in Annex I, including mixtures and natural products containing such substances. This excludes medicinal products as defined by Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use(13), pharmaceutical preparations, mixtures, natural products and other preparations containing scheduled substances that are compounded in such a way that they cannot be easily used or extracted by readily applicable or economically viable means; (b) "non-scheduled substance" means any substance which, although not listed in Annex I, is identified as having been used for the illicit manufacture of narcotic drugs or psychotropic substances; (c) "placing on the market" means any supply, whether in return for payment or free of charge, of scheduled substances in the Community; or the storage, manufacture, production, processing, trade, distribution or brokering of these substances for the purpose of supply in the Community; (d) "operator" means any natural or legal person engaged in the placing on the market of scheduled substances; (e) "International Narcotics Control Board" means the Board established by the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol; (f) "special licence" means a licence that is granted to a particular type of operator; (g) "special registration" means a registration that is made for a particular type of operator.